Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | TYMP | P19971 | 2/20 | 0.34 |
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | DHODH | Q02127 | 5/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | DHFR | P00374 | 4/20 | 0.33 |
| ▸ | CRHBP | P24387 | 1/20 | 0.31 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15987215 | 0.95 | ALDH1A1 (0.40) | ALDH1A1MAPK1MAPTLMNAHTT | |
| SCHEMBL24623524 | 0.86 | ALDH1A1 (0.40) | ALDH1A1MAPK1MAPTLMNAHTT | |
| SCHEMBL247368 | 0.85 | LMNA (0.48) | ALDH1A1MAPK1MAPTLMNAHTT | |
| SCHEMBL7704707 | 0.83 | LMNA (0.46) | ALDH1A1MAPK1MAPTLMNAHTT | |
| SCHEMBL7711087 | 0.83 | ALDH1A1 (0.50) | ALDH1A1MAPK1MAPTLMNAHTT | |
| SCHEMBL23645635 | 0.81 | ALDH1A1 (0.33) | ALDH1A1MAPK1MAPTLMNAHTT | |
| SCHEMBL24060225 | 0.81 | ALDH1A1 (0.33) | ALDH1A1MAPK1MAPTLMNAHTT | |
| SCHEMBL31305580 | 0.80 | LMNA (0.43) | ALDH1A1MAPK1MAPTLMNAHTT | |
| SCHEMBL7713106 | 0.80 | LMNA (0.48) | ALDH1A1MAPK1MAPTLMNAHTT | |
| SCHEMBL14182621 | 0.80 | LMNA (0.48) | ALDH1A1MAPK1MAPTLMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12122768-B2 | Benzonitrile derivative, light-emitting material, and light-emitting element using same | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2024-10-22 | — | — | US | disclosed |
| US-20210332032-A1 | BENZONITRILE DERIVATIVE, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT USING SAME | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2021-10-28 | — | — | US | disclosed |
| EP-3848352-A1 | BENZONITRILE DERIVATIVE, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT USING SAME | Kyushu University, National University Corporation (JP) | 2021-07-14 | — | — | EP | disclosed |
| CN-112638874-A | Benzonitrile derivative, light-emitting material, and light-emitting element using the same | 国立大学法人九州大学 | 2021-04-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12122768-B2 | Benzonitrile derivative, light-emitting material, and light-emitting element using same | INTS9, GTF2I, BRI3BP | ALDH1A1 666/4885MAPK1 3294/4885MAPT 1916/4885 |
| US-20210332032-A1 | BENZONITRILE DERIVATIVE, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT USING SAME | INTS9, GTF2I, BRI3BP | ALDH1A1 666/4885MAPK1 3294/4885MAPT 1916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.